List of Tables
Table 1. Global HDAC (histone deacetylase) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Belinostat
Table 3. Major Manufacturers of Romidepsin
Table 4. Major Manufacturers of Chidamide
Table 5. Global HDAC (histone deacetylase) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global HDAC (histone deacetylase) Inhibitor Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global HDAC (histone deacetylase) Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global HDAC (histone deacetylase) Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Region (2019-2024)
Table 10. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Region (2025-2030)
Table 11. Global HDAC (histone deacetylase) Inhibitor Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global HDAC (histone deacetylase) Inhibitor Sales by Region (2019-2024) & (Unit)
Table 13. Global HDAC (histone deacetylase) Inhibitor Sales by Region (2025-2030) & (Unit)
Table 14. Global HDAC (histone deacetylase) Inhibitor Sales Market Share by Region (2019-2024)
Table 15. Global HDAC (histone deacetylase) Inhibitor Sales Market Share by Region (2025-2030)
Table 16. Global HDAC (histone deacetylase) Inhibitor Sales by Manufacturers (2019-2024) & (Unit)
Table 17. Global HDAC (histone deacetylase) Inhibitor Sales Share by Manufacturers (2019-2024)
Table 18. Global HDAC (histone deacetylase) Inhibitor Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global HDAC (histone deacetylase) Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of HDAC (histone deacetylase) Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. HDAC (histone deacetylase) Inhibitor Price by Manufacturers 2019-2024 (USD/Unit)
Table 22. Global HDAC (histone deacetylase) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global HDAC (histone deacetylase) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HDAC (histone deacetylase) Inhibitor as of 2023)
Table 24. Global Key Manufacturers of HDAC (histone deacetylase) Inhibitor, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of HDAC (histone deacetylase) Inhibitor, Product Offered and Application
Table 26. Global Key Manufacturers of HDAC (histone deacetylase) Inhibitor, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 29. Global HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 30. Global HDAC (histone deacetylase) Inhibitor Sales Share by Type (2019-2024)
Table 31. Global HDAC (histone deacetylase) Inhibitor Sales Share by Type (2025-2030)
Table 32. Global HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global HDAC (histone deacetylase) Inhibitor Revenue Share by Type (2019-2024)
Table 35. Global HDAC (histone deacetylase) Inhibitor Revenue Share by Type (2025-2030)
Table 36. HDAC (histone deacetylase) Inhibitor Price by Type (2019-2024) & (USD/Unit)
Table 37. Global HDAC (histone deacetylase) Inhibitor Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 39. Global HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 40. Global HDAC (histone deacetylase) Inhibitor Sales Share by Application (2019-2024)
Table 41. Global HDAC (histone deacetylase) Inhibitor Sales Share by Application (2025-2030)
Table 42. Global HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global HDAC (histone deacetylase) Inhibitor Revenue Share by Application (2019-2024)
Table 45. Global HDAC (histone deacetylase) Inhibitor Revenue Share by Application (2025-2030)
Table 46. HDAC (histone deacetylase) Inhibitor Price by Application (2019-2024) & (USD/Unit)
Table 47. Global HDAC (histone deacetylase) Inhibitor Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 49. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 50. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 53. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 54. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada HDAC (histone deacetylase) Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada HDAC (histone deacetylase) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Country (2019-2024) & (Unit)
Table 60. US & Canada HDAC (histone deacetylase) Inhibitor Sales by Country (2025-2030) & (Unit)
Table 61. Europe HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 62. Europe HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 63. Europe HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 66. Europe HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 67. Europe HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe HDAC (histone deacetylase) Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe HDAC (histone deacetylase) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe HDAC (histone deacetylase) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe HDAC (histone deacetylase) Inhibitor Sales by Country (2019-2024) & (Unit)
Table 73. Europe HDAC (histone deacetylase) Inhibitor Sales by Country (2025-2030) & (Unit)
Table 74. China HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 75. China HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 76. China HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 77. China HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 78. China HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 79. China HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 80. China HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 81. China HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 83. Asia HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 84. Asia HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 87. Asia HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 88. Asia HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia HDAC (histone deacetylase) Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia HDAC (histone deacetylase) Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia HDAC (histone deacetylase) Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia HDAC (histone deacetylase) Inhibitor Sales by Region (2019-2024) & (Unit)
Table 94. Asia HDAC (histone deacetylase) Inhibitor Sales by Region (2025-2030) & (Unit)
Table 95. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Type (2019-2024) & (Unit)
Table 96. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Type (2025-2030) & (Unit)
Table 97. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Application (2019-2024) & (Unit)
Table 100. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Application (2025-2030) & (Unit)
Table 101. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Country (2019-2024) & (Unit)
Table 107. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales by Country (2025-2030) & (Unit)
Table 108. Shenzhen Chipscreen Company Information
Table 109. Shenzhen Chipscreen Description and Major Businesses
Table 110. Shenzhen Chipscreen HDAC (histone deacetylase) Inhibitor Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Shenzhen Chipscreen HDAC (histone deacetylase) Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Shenzhen Chipscreen Recent Developments
Table 113. Spectrum Pharmaceuticals Company Information
Table 114. Spectrum Pharmaceuticals Description and Major Businesses
Table 115. Spectrum Pharmaceuticals HDAC (histone deacetylase) Inhibitor Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Spectrum Pharmaceuticals HDAC (histone deacetylase) Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Spectrum Pharmaceuticals Recent Developments
Table 118. Celegne Company Information
Table 119. Celegne Description and Major Businesses
Table 120. Celegne HDAC (histone deacetylase) Inhibitor Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Celegne HDAC (histone deacetylase) Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Celegne Recent Developments
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. HDAC (histone deacetylase) Inhibitor Distributors List
Table 126. HDAC (histone deacetylase) Inhibitor Customers List
Table 127. HDAC (histone deacetylase) Inhibitor Market Trends
Table 128. HDAC (histone deacetylase) Inhibitor Market Drivers
Table 129. HDAC (histone deacetylase) Inhibitor Market Challenges
Table 130. HDAC (histone deacetylase) Inhibitor Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. HDAC (histone deacetylase) Inhibitor Product Picture
Figure 2. Global HDAC (histone deacetylase) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global HDAC (histone deacetylase) Inhibitor Market Share by Type in 2023 & 2030
Figure 4. Belinostat Product Picture
Figure 5. Romidepsin Product Picture
Figure 6. Chidamide Product Picture
Figure 7. Global HDAC (histone deacetylase) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global HDAC (histone deacetylase) Inhibitor Market Share by Application in 2023 & 2030
Figure 9. PECL Treatment
Figure 10. Other Cancers Treatment
Figure 11. HDAC (histone deacetylase) Inhibitor Report Years Considered
Figure 12. Global HDAC (histone deacetylase) Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global HDAC (histone deacetylase) Inhibitor Revenue 2019-2030 (US$ Million)
Figure 14. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Region (2019-2030)
Figure 16. Global HDAC (histone deacetylase) Inhibitor Sales 2019-2030 ((Unit)
Figure 17. Global HDAC (histone deacetylase) Inhibitor Sales Market Share by Region (2019-2030)
Figure 18. US & Canada HDAC (histone deacetylase) Inhibitor Sales YoY (2019-2030) & (Unit)
Figure 19. US & Canada HDAC (histone deacetylase) Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe HDAC (histone deacetylase) Inhibitor Sales YoY (2019-2030) & (Unit)
Figure 21. Europe HDAC (histone deacetylase) Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China HDAC (histone deacetylase) Inhibitor Sales YoY (2019-2030) & (Unit)
Figure 23. China HDAC (histone deacetylase) Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) HDAC (histone deacetylase) Inhibitor Sales YoY (2019-2030) & (Unit)
Figure 25. Asia (excluding China) HDAC (histone deacetylase) Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales YoY (2019-2030) & (Unit)
Figure 27. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The HDAC (histone deacetylase) Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of HDAC (histone deacetylase) Inhibitor in the World: Market Share by HDAC (histone deacetylase) Inhibitor Revenue in 2023
Figure 30. Global HDAC (histone deacetylase) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 32. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 33. Global HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 34. Global HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 36. US & Canada HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 38. US & Canada HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada HDAC (histone deacetylase) Inhibitor Revenue Share by Country (2019-2030)
Figure 40. US & Canada HDAC (histone deacetylase) Inhibitor Sales Share by Country (2019-2030)
Figure 41. U.S. HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 42. Canada HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 43. Europe HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 44. Europe HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 45. Europe HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 46. Europe HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 47. Europe HDAC (histone deacetylase) Inhibitor Revenue Share by Country (2019-2030)
Figure 48. Europe HDAC (histone deacetylase) Inhibitor Sales Share by Country (2019-2030)
Figure 49. Germany HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 50. France HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 52. Italy HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 53. Russia HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 54. China HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 55. China HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 56. China HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 57. China HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 58. Asia HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 59. Asia HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 60. Asia HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 61. Asia HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 62. Asia HDAC (histone deacetylase) Inhibitor Revenue Share by Region (2019-2030)
Figure 63. Asia HDAC (histone deacetylase) Inhibitor Sales Share by Region (2019-2030)
Figure 64. Japan HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 68. India HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America HDAC (histone deacetylase) Inhibitor Sales Share by Country (2019-2030)
Figure 75. Brazil HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 78. Israel HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries HDAC (histone deacetylase) Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 80. HDAC (histone deacetylase) Inhibitor Value Chain
Figure 81. HDAC (histone deacetylase) Inhibitor Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed